These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3837790)

  • 1. The effect of cycloheximide, heparin and ancrod on mice given Ehrlich ascites tumour cells intravenously.
    Parry EW
    J Comp Pathol; 1985 Apr; 95(2):203-7. PubMed ID: 3837790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal susceptibility to cycloheximide of mice bearing Ehrlich ascites tumours and of animals pretreated with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1988 Oct; 99(3):309-15. PubMed ID: 3204165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lethal syndrome following intravenous injection of Ehrlich ascites tumour cells in cycloheximide-treated mice and its prevention by heparin.
    Parry EW
    J Comp Pathol; 1984 Jan; 94(1):93-9. PubMed ID: 6699233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors involved in the fatal susceptibility to submicrogram doses of endotoxin in cycloheximide-treated mice.
    Parry EW
    J Comp Pathol; 1989 Jan; 100(1):13-8. PubMed ID: 2645318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further analysis of lethal factors in cycloheximide-treated mice given low doses of bacterial lipopolysaccharide.
    Parry EW
    J Comp Pathol; 1989 Feb; 100(2):155-60. PubMed ID: 2715398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycloheximide treatment modifies the pattern of "metastasis" following intravenous injection of Ehrlich ascites tumour cells.
    Parry EW
    Gan; 1981 Jun; 72(3):464-7. PubMed ID: 7319203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycloheximide challenge of mice bearing subcutaneous tumours, with observations on heparin treatment.
    Parry EW
    J Comp Pathol; 1984 Jan; 94(1):101-6. PubMed ID: 6699220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocortisone protects cycloheximide-challenged mice pretreated with Ehrlich ascites tumour cells or with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1990 Oct; 103(3):315-9. PubMed ID: 2258469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cycloheximide and carbon tetrachloride in Ehrlich ascites tumour-bearing mice.
    Parry EW
    Gan; 1980 Jun; 71(3):275-9. PubMed ID: 7418971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravenously injected Ehrlich ascites tumour cells in cycloheximide-treated mice.
    Parry EW
    Gan; 1980 Dec; 71(6):907-9. PubMed ID: 7306373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of endotoxin pretreatment on subsequent challenge of mice with cycloheximide and a small dose of endotoxin.
    Parry EW
    J Comp Pathol; 1989 Nov; 101(4):381-8. PubMed ID: 2607012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of fatalities in cycloheximide challenged mice pretreated with a submicrogram dose of lipopolysaccharide or with a small volume of cell-free Ehrlich ascites tumour fluid.
    Parry EW
    Inflamm Res; 1998 Jan; 47(1):8-11. PubMed ID: 9495580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lethal syndrome in mice following administration of carbon tetrachloride and cycloheximide, and its prevention by heparin treatment.
    Parry EW
    J Comp Pathol; 1984 Oct; 94(4):505-8. PubMed ID: 6512024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrination with ancrod: effect on reticuloendothelial clearance of circulating immune complexes.
    Barcelli U; Rademacher PR; Ooi BS; Pollak VE
    Nephron; 1982; 30(4):314-7. PubMed ID: 7110462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of heparin on glomerular coagulation induced in mice by cycloheximide and bacterial lipopolysaccharide.
    Parry EW
    J Comp Pathol; 1991 Feb; 104(2):121-7. PubMed ID: 1865022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog.
    Daniel TM; Pizzo SV; Mckee PA
    Ann Surg; 1976 Aug; 184(2):223-8. PubMed ID: 952568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation following defibrination with ancrod.
    Slade CL; Andes WA; Mason AD
    Thromb Haemost; 1976 Nov; 36(2):424-9. PubMed ID: 1036842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of angrod on the delayed hypersensitivity response in rats.
    Silberman S; Kwaan HC
    Br J Exp Pathol; 1975 Feb; 56(1):44-51. PubMed ID: 1203167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of enteric bacteria in the pathogenesis of fatal cycloheximide intolerance in mice pretreated with dexamethasone, promethazine or nordihydroguaiaretic acid.
    Parry EW
    Inflamm Res; 1996 Jul; 45(7):354-6. PubMed ID: 8841837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some inhibitory effects of (--)-emetine on growth of Ehrlich ascites carcinoma.
    Johnson RK; Jondorf WR
    Biochem J; 1974 Apr; 140(1):87-94. PubMed ID: 4451553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.